MannKind Corp (NASDAQ:MNKD)
| 3.07 Delayed Data As of Nov 23 |  +0.16 / +5.52%Today’s Change | 0.80 Today|||52-Week Range 3.20 | +137.98% Year-to-Date |
Latest MNKD News | Press Releases
No recent news for MannKind Corp.
Today’s Trading
| Previous close | 2.90 |
| Today’s open | 3.00 |
| Day’s range | 2.90 - 3.10 |
| Volume | 4,586,536 |
| Average volume (3 months) | 2,535,410 |
| Market cap | $644.3M |
Data as of 3:59pm ET, 11/23/2020
Growth & Valuation
| Earnings growth (last year) | +56.02% |
| Earnings growth (this year) | +33.24% |
| Earnings growth (next 5 years) | +30.20% |
| Revenue growth (last year) | +126.28% |
| P/E ratio | NM |
| Price/Sales | 4.00 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VNDAVanda Pharmaceutical... | -0.14 | -1.13% |
| ALBOAlbireo Pharma Inc | -0.90 | -2.56% |
| GOSSGossamer Bio Inc | -0.21 | -2.33% |
| STROSutro Biopharma Inc | -1.91 | -10.63% |
Data as of 3:59pm ET, 11/23/2020
Financials
| Next reporting date | March 2, 2021 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $63.0M |
| Annual profit (last year) | -$51.9M |
| Net profit margin | -82.34% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Westlake Village, California |
Forecasts
